Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

120
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
120
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

64
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
64
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

111
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
111
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

150
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
150
Heart Valves01:16

Heart Valves

9.4K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
9.4K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

121
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology.

Cardiovascular research·2026
Same author

Combined Intraepidermal-Intranuclear IgG and "Full-House" Immunoreactant Deposition at the Dermoepidermal Junction in Patients With Bullous Systemic Lupus Erythematosus.

The American Journal of dermatopathology·2025
Same author

Hepatovascular manifestation of Takayasu arteritis presenting as sudden cardiac death.

Journal of forensic and legal medicine·2025
Same author

Comparison of modes of failure and clinical outcomes between explanted porcine and bovine pericardial bioprosthetic valves.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2023
Same author

Post mortem computed tomography is highly sensitive for pyelonephritis. A radiologic-pathologic correlation series.

Forensic science, medicine, and pathology·2022
Same author

Symptomatic congenital saccular aneurysm of the inferior vena cava associated with a circumaortic left renal vein.

Journal of vascular surgery cases·2021

Related Experiment Video

Updated: Nov 5, 2025

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.3K

Valve-in-valve prosthesis-late morphological findings.

Patrick J H Kim1, Natasha Richards2, Christopher M S Feindel3

  • 1University of Toronto, Departments of Laboratory Medicine & Pathobiology & Departments of Pathology & Cardiovascular Surgery, Toronto General Hospital, University Health Network, Toronto, Canada.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|May 14, 2021
PubMed
Summary
This summary is machine-generated.

Transcatheter aortic valve implantation (TAVI) is widely used, but long-term durability data and understanding of failed valve pathology are lacking. This case report details a late explanted valve-in-valve (VIV) bioprosthesis, highlighting the need for more research.

Keywords:
bioprosthesistranscatheter aortic valve implantationvalve-in valve

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.3K

Related Experiment Videos

Last Updated: Nov 5, 2025

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.3K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.1K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.3K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Pathology

Background:

  • Transcatheter aortic valve implantation (TAVI) is a primary treatment for severe aortic stenosis.
  • The valve-in-valve (VIV) procedure, used for failed bioprosthetic valves since 2007, has seen rapid adoption.
  • Limited long-term durability data and understanding of TAVI bioprosthesis failure exist, especially post-VIV.

Observation:

  • Presents a case of a 65-year-old male with a late explanted VIV bioprosthesis.
  • The explanted valve had undergone 10 years of service post-initial aortic valve replacement and 5 years post-VIV procedure.
  • Multiple morphologic findings were observed in the explanted VIV bioprosthesis.

Findings:

  • The explanted valve demonstrated significant degeneration after a prolonged period.
  • Detailed morphologic analysis revealed specific patterns of tissue breakdown.
  • This case provides valuable insights into the pathology of degenerated TAVI bioprostheses in a VIV context.

Implications:

  • Standardized morphologic data from explanted TAVI valves are crucial for understanding tissue degeneration.
  • Such data can aid in identifying early interventional strategies to improve patient outcomes.
  • Further research is essential to establish long-term TAVI and VIV bioprosthesis durability and failure mechanisms.